Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravaginal botulinum toxin A for overactive bladder
IRCT20211203053261N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of botulinum toxin type A in overactive bladder (OAB), sponsored by Shahid Beheshti University of Medical Sciences. Started Dec 2021; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on IRCT20211203053261N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211203053261N1.